These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19621504)

  • 1. [Appropriate use of immunosuppressants after renal transplantation].
    Tian Y; Xie ZL; Tang YW; Sun W; Guo HB; Zhang L; Lin J; Ma LL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Jun; 31(3):256-8. PubMed ID: 19621504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Problems with the follow-up and aftercare of transplanted patients exemplified by kidney transplantation].
    Graeb C; Fischereder M
    MMW Fortschr Med; 2004 Jun; 146(24):38-41. PubMed ID: 15366490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of renal transplantation.
    Hashmi S; Poommipanit N; Kahwaji J; Bunnapradist S
    Minerva Med; 2007 Dec; 98(6):713-29. PubMed ID: 18299684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchiectasis in children after renal or liver transplantation: a report of five cases.
    Pijnenburg MW; Cransberg K; Wolff E; Bouquet J; Merkus PJ
    Pediatr Transplant; 2004 Feb; 8(1):71-4. PubMed ID: 15009844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Awareness of memory impairment increases the adherence to immunosuppressants in kidney transplant recipients.
    Cheng CY; Lin BY; Chang KH; Shu KH; Wu MJ
    Transplant Proc; 2012 Apr; 44(3):746-8. PubMed ID: 22483484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive therapy in renal transplantation.
    Fedric TN
    Crit Care Nurs Clin North Am; 1990 Mar; 2(1):123-31. PubMed ID: 2357308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.3.2. Long-term immunosuppression. Therapy conversion.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():20-1. PubMed ID: 12091625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopharmacologic therapy in renal transplantation.
    Shoker AS
    Pharmacotherapy; 1996; 16(4):562-75. PubMed ID: 8840362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Post-transplantation malignant tumors and the challenges of immunosuppressive therapy in transplanted patients developing lymphoma. Mycophenolic acid as a possibility].
    Végso G
    Magy Onkol; 2009 Jun; 53(2):149-56. PubMed ID: 19581181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid withdrawal after long-term medication for immunosuppressive therapy in renal transplant patients: adrenal response and clinical implications.
    Miozzari M; Ambühl PM
    Nephrol Dial Transplant; 2004 Oct; 19(10):2615-21. PubMed ID: 15280521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of different long-term maintenance immunosuppressive therapy strategies on patients' outcome after heart transplantation.
    Dandel M; Lehmkuhl HB; Knosalla C; Hetzer R
    Transpl Immunol; 2010 Jul; 23(3):93-103. PubMed ID: 20434559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of immunosuppressive drugs in kidney transplantation.
    Salomon DR
    Pharmacotherapy; 1991; 11(6):153S-164S. PubMed ID: 1771141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present and future of immunosuppressive therapy in kidney transplantation.
    Ponticelli C
    Transplant Proc; 2011; 43(6):2439-40. PubMed ID: 21839286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive therapy and its problems].
    Kuman M
    Vnitr Lek; 2011; 57(7-8):655-8. PubMed ID: 21877602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role and value of sirolimus administration in kidney and liver transplantation.
    Mehrabi A; Fonouni H; Kashfi A; Schmied BM; Morath Ch; Sadeghi M; Schemmer P; Encke J; Sauer P; Zeier M; Weitz J; Büchler MW; Schmidt J
    Clin Transplant; 2006; 20 Suppl 17():30-43. PubMed ID: 17100699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term care and nursing management of a patient who is the recipient of a renal transplant.
    Whittaker C; Dunsmore V; Murphy F; Rolfe C; Trevitt R
    J Ren Care; 2012 Dec; 38(4):233-40. PubMed ID: 23176578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The follow-up of kidney transplant patients].
    Helanterä I; Saha H; Koskinen P
    Duodecim; 2010; 126(22):2601-8. PubMed ID: 21188876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal transplantation, immunosuppression and the skin: an update.
    Moloney FJ; de Freitas D; Conlon PJ; Murphy GM
    Photodermatol Photoimmunol Photomed; 2005 Feb; 21(1):1-8. PubMed ID: 15634217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.